반응식
Br[C:2]1[CH:3]=[N:4][N:5]([CH3:9])[C:6]=1[CH2:7][OH:8].[CH3:10][O:11][C:12]1[CH:18]=[C:17](B2OC(C)(C)C(C)(C)O2)[CH:16]=[CH:15][C:13]=1[NH2:14]>>[NH2:14][C:13]1[CH:15]=[CH:16][C:17]([C:2]2[CH:3]=[N:4][N:5]([CH3:9])[C:6]=2[CH2:7][OH:8])=[CH:18][C:12]=1[O:11][CH3:10]참가 물질
3
실험 절차
The title compound was prepared according to the method described for Preparation 158 using (4-bromo-1-methyl-1H-pyrazol-5-yl)methanol (Preparation 222) and 2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline. The residue was purified using Biotage silica gel column chromatography eluting with EtOAc followed by elution through an SCX-2 cartridge.
후처리
- customThe residue was purified
- washeluting with EtOAc
- washfollowed by elution through an SCX-2 cartridge
출처 및 근거
- ORD 기록
- ord-bcb834331b3f43909113504e5aa25ee0
- 출처 데이터셋
- uspto-grants-2016_08
- 특허 번호
- US09409907B2
연결된 노트
불러오는 중…